97-17849. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cooperative Agreements for Competitive Innovations in Syphilis Prevention in the United States: Reconsidering the Epidemiology and Involving Communities, ...  

  • [Federal Register Volume 62, Number 131 (Wednesday, July 9, 1997)]
    [Notices]
    [Page 36827]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-17849]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Disease, Disability, and Injury Prevention and Control Special 
    Emphasis Panel (SEP): Cooperative Agreements for Competitive 
    Innovations in Syphilis Prevention in the United States: Reconsidering 
    the Epidemiology and Involving Communities, Phase II: Evaluation of a 
    Community Intervention, Program Announcement 523: Meeting
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following committee meeting.
    
        Name: Disease, Disability, and Injury Prevention and Control 
    SEP: Cooperative Agreements for Competitive Innovations in Syphilis 
    Prevention in the United States: Reconsidering the Epidemiology and 
    Involving Communities, Phase II: Evaluation of a Community 
    Intervention, Program Announcement 523.
        Time and Date: 8:30 a.m.-5 p.m., August 12, 1997.
        Place: 11 Corporate Square Boulevard, Conference Room A, 
    Atlanta, Georgia 30329.
        Status: Closed.
        Matters to be discussed: The meeting will include the review, 
    discussion, and evaluation of applications received in response to 
    Program Announcement 523.
        The meeting will be closed to the public in accordance with 
    provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., 
    and the Determination of the Associate Director for Management and 
    Operations, CDC, pursuant to Pub. L. 92-463.
        Contact Person For More Information: John R. Lehnherr, Chief, 
    Prevention Support Office, National Center for HIV, STD, and TB 
    Prevention, CDC, M/S E07, 1600 Clifton Road, NE, Atlanta, Georgia 
    30333, telephone 404/639-8025.
    
        Dated: July 2, 1997.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 97-17849 Filed 7-8-97; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
07/09/1997
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
97-17849
Dates:
8:30 a.m.-5 p.m., August 12, 1997.
Pages:
36827-36827 (1 pages)
PDF File:
97-17849.pdf